Showing results (1291-1300 of 1,598) with videos related to

Sort By:
Pageof 160
JAMA Psychiatry|February 1, 2013
Potential of pretreatment neural activity in the visual cortex during emotional processing to predict treatment response to scopolamine in major depressive disorderMaura L Furey, Wayne C Drevets, Elana M Hoffman, et al.
JAMA Psychiatry|February 14, 2013
Brain surface anatomy in adults with autism: the relationship between surface area, cortical thickness, and autistic symptomsChristine Ecker, Cedric Ginestet, Yue Feng, et al.
JAMA Psychiatry|February 14, 2013
Traffic-related air pollution, particulate matter, and autismHeather E Volk, Fred Lurmann, Bryan Penfold, et al.
JAMA Psychiatry|January 11, 2013
Evidence for increased glutamatergic cortical facilitation in children and adolescents with major depressive disorderPaul E Croarkin, Paul A Nakonezny, Mustafa M Husain, et al.
JAMA Psychiatry|March 1, 2013
Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysisLori E Ross, Sophie Grigoriadis, Lana Mamisashvili, et al.
JAMA Psychiatry|May 24, 2013
Population-based, multigenerational family clustering study of obsessive-compulsive disorderDavid Mataix-Cols, Marcus Boman, Benedetta Monzani, et al.
JAMA Psychiatry|June 14, 2013
Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide studyMichael E Benros, Berit L Waltoft, Merete Nordentoft, et al.
JAMA Psychiatry|July 30, 2013
A comprehensive family-based replication study of schizophrenia genesKarolina A Aberg, Youfang Liu, Jozsef Bukszár, et al.
JAMA Psychiatry|September 6, 2013
Prediction of functional outcome in individuals at clinical high risk for psychosisRicardo E Carrión, Danielle McLaughlin, Terry E Goldberg, et al.
JAMA Psychiatry|August 16, 2013
Cortical folding defects as markers of poor treatment response in first-episode psychosisLena Palaniyappan, Tiago Reis Marques, Heather Taylor, et al.
Pageof 160